Teleflex awarded short-term central venous catheters contract from Vizient

More on Teleflex

• Teleflex Incorporated: Compelling Only On One Metric
• Teleflex Incorporated (TFX) Q3 2024 Earnings Call Transcript
• Seeking Alpha | January 9, 2025

Teleflex awarded Short Term Central Venous Catheters contract from Vizient

Including market leading Arrow™ CVCs and Arterial CathetersWAYNE, Pa., Jan. 09, 2025 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced it has been awarded a contract by Vizient, Inc., the largest provider-driven healthcare performance improvement company in the U.S. The agreement, effective January 1, 2025, covers the supply of Teleflex’s Central Venous Access Catheters and Arterial Catheters. Vizient provides solutions and

Yahoo | January 9, 2025

Teleflex to Present at the 43rd Annual J.P. Morgan Healthcare Conference

WAYNE, Pa., Jan. 07, 2025 (GLOBE NEWSWIRE) -- Liam Kelly, Chairman, President and CEO, Teleflex Incorporated (NYSE: TFX), is scheduled to speak at the 43rd Annual J.P. Morgan Healthcare Conference at The Westin St. Francis in San Francisco, California, on Tuesday, January 14, 2025, at 5:15 p.m. (PT). A live audio webcast of the conference presentation, along with the accompanying slide presentation, will be available on the investor section of the Teleflex website at teleflex.com. About Teleflex

Yahoo | January 7, 2025

Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Yahoo | December 26, 2024

Here's Why Teleflex (TFX) is a Strong Value Stock

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Yahoo | December 23, 2024

Should You Retain Teleflex Stock in Your Portfolio Right Now?

TFX stays on investors' radars due to its performance in the Vascular Access segment and expansion moves.

Yahoo | December 23, 2024

Teleflex price target lowered to $200 from $227 at Truist

Truist lowered the firm’s price target on Teleflex (TFX) to $200 from $227 and keeps a Hold rating on the shares as part of a broader research note previewing 2025 in Medical Technology. The firm sees the sector as “one of the better/safer houses” in healthcare given its lower “front-line” exposure to healthcare policy rhetoric that is tied to the administration change as well as its position as an “innovation segment” with sustainable above-average revenue and EPS growth, strong balance sheets,

Yahoo | December 19, 2024

Teleflex Expands CVC Portfolio in EMEA With New Launch: Stock to Gain?

Teleflex introduces the Arrowg+ard Blue Plus MSB Procedure Kit in the EMEA.

Yahoo | December 16, 2024

What Does Teleflex Incorporated's (NYSE:TFX) Share Price Indicate?

While Teleflex Incorporated ( NYSE:TFX ) might not have the largest market cap around , it saw significant share price...

Yahoo | December 13, 2024

Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Yahoo | December 10, 2024